Objective Belgian genetic centers established a database containing data on all chromosomal microarrays performed in a prenatal context. A study was initiated to evaluate postnatal development in children diagnosed prenatally with a non-benign copy number variant (CNV). Methods All children diagnosed with a prenatally detected non-benign CNV in a Belgian genetic center between May 2013 and February 2015 were included in the patient population. The control population consisted of children who had undergone an invasive procedure during pregnancy, with no or only benign CNVs. Child development was evaluated at 36 months using three (3) questionnaires: Ages and Stages Questionnaire Third edition, Ages and Stages Questionnaire Social-Emotional S...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
Chromosomal microarray analysis (CMA) is the first-tier test for developmental delay, autism spectru...
peer reviewedObjective: Belgian genetic centers established a database containing data on all chromo...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objectives : Since 2013, samples for prenatal diagnosis in Belgium are analysed by Chromosomal Micro...
International audienceObjective - To determine the frequency and nature of copy number variants (CNV...
Abstract Background The implementation of genomic testing in pregnancy means that couples have acces...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
Chromosomal microarray analysis (CMA) is the first-tier test for developmental delay, autism spectru...
peer reviewedObjective: Belgian genetic centers established a database containing data on all chromo...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objectives : Since 2013, samples for prenatal diagnosis in Belgium are analysed by Chromosomal Micro...
International audienceObjective - To determine the frequency and nature of copy number variants (CNV...
Abstract Background The implementation of genomic testing in pregnancy means that couples have acces...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
Chromosomal microarray analysis (CMA) is the first-tier test for developmental delay, autism spectru...